Bill of Health

NOVEMBER 7, 2023

One of us (LG) was involved in the drafting of the Siracusa Principles, which have become the chief international instrument governing permissible human rights limitations during national emergencies. States must use the least restrictive means available when putting in place rights-restricting measures.

COVID-19 284

COVID-19 Public Health World Health Governance 284

Bill of Health

MARCH 24, 2022

At the research and development (R&D) stage, government funders can bind producers to equity goals through targeted contractual provisions, as we explain in a recently-published Nature Biotechnology article. Consider, for instance, the case of COVID-19 vaccines. Pandemic Technology and the Contract Landscape.

COVID-19 Vaccine 130

COVID-19 Vaccine Licensing COVID-19 Public Health 130

Healthcare IT Today

DECEMBER 23, 2020

The following is a guest article by Kurt Waltenbaugh, CEO at Carrot Health.

COVID-19 Vaccine 85

COVID-19 Vaccine COVID-19 Public Health Governance 85

Bill of Health

SEPTEMBER 20, 2023

By Ana Santos Rutschman What can the New York City Marathon experience teach those reflecting on ways to increase equity in the transnational allocation of scarce vaccine doses? Vaccines are pharmaceutical products, a critical tool in public and global health. Quite a lot, it turns out.

Public Health 307

Public Health COVID-19 COVID-19 Vaccine Governance 307

Bill of Health

AUGUST 29, 2022

On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. government funding, announced that it felt “a special obligation … to use our resources to bring this pandemic to an end as quickly as possible.” By Jorge L. Pandemic Pledges.

COVID-19 Vaccine 362

COVID-19 Vaccine COVID-19 Licensing Governance 362

Bill of Health

OCTOBER 31, 2023

While the Principles and Guidelines on Human Rights and Public Health Emergencies (the Principles) do not make explicit reference to infodemics, the application of digital technologies in response to a public health emergency is a clear concern.

Public Health 201

Public Health COVID-19 World Health COVID-19 Vaccine 201

SQA

APRIL 30, 2021

Commission Extends Transparency and Authorization Mechanism for Exports of COVID-19 Vaccines, 11 March 2021. The EC has extended until the end of June 2021 the transparency and authorization mechanism for COVID-19 vaccine exports. The EU continues to be the leading provider of vaccines around the world.

COVID-19 Vaccine 52

COVID-19 Vaccine COVID-19 Compliance Governance 52